Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 3,282 | 3,122 | 3,051 | 3,364 | 2,582 |
| Cost of Goods | 883 | 1,080 | 996 | 1,315 | 1,595 |
| Gross Profit | 2,399 | 2,043 | 2,055 | 2,049 | 987 |
| Operating Expenses | 4,507 | 3,787 | 4,602 | 3,949 | 4,061 |
| Operating Income | -1,226 | -1,665 | -1,551 | -1,585 | -2,480 |
| Interest Expense | 0 | 0 | 0 | 0 | 4 |
| Other Income | -73 | 34 | -1 | -24 | 77 |
| Pre-tax Income | -1,299 | -1,631 | -1,552 | -1,609 | -2,407 |
| Net Income Continuous | -1,299 | -1,631 | -1,552 | -1,609 | -2,407 |
| Net Income | $-1,299 | $-1,631 | $-1,552 | $-1,609 | $-2,407 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EBITDA(a) | $-1,174 | $-1,616 | $-1,507 | $-1,541 | $-2,429 |